University of Southern California
Dr. Wei Li and colleagues made the original discovery of the compound in our HSP90 project. They are instrumental in helping grant research and providing scientific expertise in furthering this venture.
Amoytop Biotech Co., Ltd
Amoytop Biotech is our strategic partner for fast and cost-effective preclinical drug development. Amoytop is one of the Top 10 biotechnology companies in China with revenues expected to top $1 billion dollars in 2015. Amoytop has successfully created a complete pipeline from research and development to large scale production capabilities to marketing and sales.